Direkt zum Inhalt
Merck

Spatially restricted hyaluronan production by Has2 drives epithelial tubulogenesis in vitro.

American journal of physiology. Cell physiology (2014-08-29)
Priscilla Soulié, Alexandra Chassot, Thomas Ernandez, Roberto Montesano, Eric Féraille
ZUSAMMENFASSUNG

Generation of branched tubes from an epithelial bud is a fundamental process in development. We hypothesized that induction of hyaluronan synthase (Has) and production of hyaluronan (HA) drives tubulogenesis in response to morphogenetic cytokines. Treatment of J3B1A mammary cells with transforming growth factor-β1 or renal MDCK and mCCD-N21 cells with hepatocyte growth factor induced strong and specific expression of Has2. Immunostaining revealed that HA was preferentially produced at the tips of growing tubules. Inhibition of HA production, either by 4-methylumbelliferone (4-MU) or by Has2 mRNA silencing, abrogated tubule formation. HA production by J3B1A and mCCD-N21 cells was associated with sustained activation of ERK and S6 phosphorylation. However, silencing of either CD44 or RHAMM (receptor for HA-mediated motility), the major HA receptors, by RNA interference, did not alter tubulogenesis, suggesting that this process is not receptor-mediated.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumselenit, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Natriumselenit, 99%
Sigma-Aldrich
Natriumselenit, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Sigma-Aldrich
4-Methyl-umbelliferon, ≥98%
Sigma-Aldrich
Selensäure, 98%
USP
Tretinoin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Selensäure, 99.999% trace metals basis
Sigma-Aldrich
Natriumselenit, anhydrous, ≥90.0% (RT)
Supelco
Retinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Tretinoin, European Pharmacopoeia (EP) Reference Standard
Hymecromon, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Has2
Sigma-Aldrich
MISSION® esiRNA, targeting human HAS2